Michael Bartholomew
About Michael Bartholomew
Michael Bartholomew is an experienced executive and co-founder with a strong background in driving growth in the medical device and biopharma sectors. He currently serves as EVP and Co-Founder at Promaxo and has held various advisory roles while also co-founding Neuro42, focusing on innovative neurological disease interventions.
Current Role at Promaxo
Michael Bartholomew serves as Executive Vice President and Co-Founder at Promaxo, where he has been an Inside Director on the Board of Directors since 2016. His role involves overseeing strategic initiatives and driving the company's growth in the medical technology sector. Promaxo focuses on developing innovative imaging solutions to enhance patient care.
Professional Experience
Michael Bartholomew has extensive experience in the healthcare and life sciences industries. He is currently an Advisor at Navaux and 8chili, and serves as Co-Founder and Advisor to the Board of Directors at neuro42, where he focuses on integrating advanced technologies for neurological disease interventions. His previous roles include Vice President of Sales & Marketing at Dohmen Life Science Services and Senior Sales Leader at Pfizer.
Education and Expertise
Michael Bartholomew earned a Bachelor of Arts in Economics from Indiana University Bloomington and a Master of Science in Administration with Highest Distinction from Central Michigan University. His educational background supports his specialization in the commercialization of medical devices and biopharma products, contributing to his successful career in driving growth and profitability.
Military Service
Michael Bartholomew served in the US Air Force as a decorated combat aviator, achieving the rank of Captain. His military experience has contributed to his leadership skills and strategic thinking, which he applies in his various roles in the healthcare industry.
Board Memberships and Advisory Roles
In addition to his role at Promaxo, Michael Bartholomew holds advisory positions at Otomagnetics, Inc and has served on the Board of Directors for Achelios Therapeutics. His involvement in these organizations highlights his commitment to advancing healthcare solutions and his expertise in the commercialization of medical technologies.